As of 2024-12-11, the EV/EBITDA ratio of Health Catalyst Inc (HCAT) is -22.95. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. HCAT's latest enterprise value is 526.02 mil USD. HCAT's TTM EBITDA according to its financial statements is -22.92 mil USD. Dividing these 2 quantities gives us the above HCAT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.8x - 16.9x | 14.0x |
| Forward P/E multiples | 16.3x - 19.4x | 17.8x |
| Fair Price | (6.41) - (6.66) | (6.26) |
| Upside | -176.6% - -179.5% | -174.8% |
| Date | EV/EBITDA |
| 2024-12-09 | -22.87 |
| 2024-12-06 | -22.90 |
| 2024-12-05 | -22.63 |
| 2024-12-04 | -21.78 |
| 2024-12-03 | -21.81 |
| 2024-12-02 | -24.67 |
| 2024-11-29 | -24.17 |
| 2024-11-27 | -23.69 |
| 2024-11-26 | -23.29 |
| 2024-11-25 | -23.35 |
| 2024-11-22 | -22.31 |
| 2024-11-21 | -21.06 |
| 2024-11-20 | -20.27 |
| 2024-11-19 | -20.74 |
| 2024-11-18 | -20.72 |
| 2024-11-15 | -21.04 |
| 2024-11-14 | -23.16 |
| 2024-11-13 | -23.72 |
| 2024-11-12 | -22.31 |
| 2024-11-11 | -22.82 |
| 2024-11-08 | -22.60 |
| 2024-11-07 | -24.25 |
| 2024-11-06 | -22.63 |
| 2024-11-05 | -21.33 |
| 2024-11-04 | -21.12 |
| 2024-11-01 | -21.17 |
| 2024-10-31 | -21.36 |
| 2024-10-30 | -22.07 |
| 2024-10-29 | -21.73 |
| 2024-10-28 | -21.78 |
| 2024-10-25 | -21.06 |
| 2024-10-24 | -21.38 |
| 2024-10-23 | -22.18 |
| 2024-10-22 | -23.64 |
| 2024-10-21 | -23.56 |
| 2024-10-18 | -23.72 |
| 2024-10-17 | -23.69 |
| 2024-10-16 | -23.88 |
| 2024-10-15 | -23.35 |
| 2024-10-14 | -22.58 |
| 2024-10-11 | -22.34 |
| 2024-10-10 | -21.57 |
| 2024-10-09 | -21.73 |
| 2024-10-08 | -21.51 |
| 2024-10-07 | -20.96 |
| 2024-10-04 | -21.17 |
| 2024-10-03 | -20.98 |
| 2024-10-02 | -21.70 |
| 2024-10-01 | -22.10 |
| 2024-09-30 | -22.34 |